IN8bio, Inc.
INABNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $23.07M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.88$2.73
- Volume (live)
- -
- Avg. volume (3M)
- 44.80K
IN8bio (INAB) Stock Price & Financial Analysis
IN8bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.06 - $1.18 |
|---|---|
| 52-Week High | $2.73 |
| 52-Week Low | $0.88 |
| Open | $1.17 |
| Volume (last close) | 31.70K |
| Average Volume (3M) | 44.80K |
| 50-Day MA | $1.16 |
|---|---|
| 200-Day MA | $1.53 |
| 1-Year Change | −42.75% |
| Market Cap | 23.07M |
|---|---|
| Shares Outstanding | 19.47M |
| Price to Book (P/B) | 1.26 |
| EV/EBITDA | -0.43 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
IN8bio at a Glance
As of the Oct 16, 2026 close, IN8bio (INAB) has a market capitalization of $23.07M.
As of its latest reported balance sheet, it holds $17.96M in cash and securities against $2.18M of debt, a net cash position of $15.78M.
IN8bio does not currently pay a dividend.
The share price is down 42.8% over the past year. At $1.11 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.88 to $2.73, below its 200-day moving average of $1.53.
Frequently Asked Questions About IN8bio
What is the current stock price for INAB?
As of the Oct 16, 2026 close, INAB stock trades at $1.11. The 52-week range is $0.88–$2.73, with a day range of $1.06–$1.18.
What is the P/E ratio for INAB?
The P/E ratio (Price-to-Earnings) for INAB is shown in the Key Statistics section. This valuation metric helps compare IN8bio, Inc. to industry peers.
Does INAB pay dividends?
IN8bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for INAB?
Analyst ratings and recommendations for INAB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of INAB?
As of the Oct 16, 2026 close, IN8bio's market capitalization is $21.6M, classifying it as a micro-cap company. IN8bio operates in the Healthcare sector within the Biotechnology industry.